Literature DB >> 2249047

What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.

J Scott1, I Johnston, J Britton.   

Abstract

OBJECTIVE: To investigate the role of occupational and domestic exposure to dust in the aetiology of cryptogenic fibrosing alveolitis.
DESIGN: Matched case-control study.
SUBJECTS: 40 Patients with cryptogenic fibrosing alveolitis and 106 community controls matched for age and sex who responded to a questionnaire. MAIN OUTCOME MEASURE: Responses to self administered questionnaire asking about lifetime exposure to dust, animals, and smoke at home and at work.
RESULTS: The patients with cryptogenic fibrosing alveolitis were more likely to report occupational exposure to metal dust (matched odds ratio 10.97 (95% confidence interval 2.30 to 52.4), p less than 0.001) or wood dust (2.94 (0.87 to 9.90), p = 0.08), to have worked with cattle (10.89 (1.24 to 96.0), p = 0.01), and to have lived in a house heated by a wood fire (12.55 (1.04 to 114), p = 0.009). A history of smoking and social class based on occupation were not significantly related to disease state.
CONCLUSION: Environmental exposure to dust may be an important factor in the aetiology of cryptogenic fibrosing alveolitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249047      PMCID: PMC1664043          DOI: 10.1136/bmj.301.6759.1015

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  12 in total

1.  Pulmonary gamma interferon production in patients with fibrosing alveolitis.

Authors:  B W Robinson; A H Rose
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

2.  The prognosis of cryptogenic fibrosing alveolitis.

Authors:  B H Stack; Y F Choo-Kang; B E Heard
Journal:  Thorax       Date:  1972-09       Impact factor: 9.139

3.  Diffuse interstitial lung disease associated with hydrogen peroxide inhalation in a dairy worker.

Authors:  R M Kaelin; Y Kapanci; J M Tschopp
Journal:  Am Rev Respir Dis       Date:  1988-05

Review 4.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

5.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-03       Impact factor: 9.139

6.  Rising mortality from cryptogenic fibrosing alveolitis.

Authors:  I Johnston; J Britton; W Kinnear; R Logan
Journal:  BMJ       Date:  1990-11-03

Review 7.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects.

Authors:  R G Crystal; J D Fulmer; W C Roberts; M L Moss; B R Line; H Y Reynolds
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

8.  Epidemiological study of farmer's lung in five districts of the French Doubs province.

Authors:  A Depierre; J C Dalphin; D Pernet; A Dubiez; C Faucompré; J L Breton
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

9.  Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.

Authors:  D Valeyre; P Soler; C Clerici; J Pré; J P Battesti; R Georges; A J Hance
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

10.  Cryptogenic fibrosing alveolitis in children.

Authors:  A Chetty; U N Bhuyan; D K Mitra; S Roy; A Deorari
Journal:  Ann Allergy       Date:  1987-05
View more
  40 in total

Review 1.  In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 2.  Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.

Authors:  J Britton
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 3.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 4.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 5.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

6.  Critical appraisal of published research: introductory guidelines.

Authors:  F G Fowkes; P M Fulton
Journal:  BMJ       Date:  1991-05-11

7.  Occupational exposure in patients with the antisynthetase syndrome.

Authors:  Ane Labirua-Iturburu; Albert Selva-O'Callaghan; Jan-Paul Zock; Ramon Orriols; Xavier Martínez-Gómez; Miquel Vilardell-Tarrés
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

8.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

Authors:  David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

9.  Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.

Authors:  R Hubbard; A Venn
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

10.  Mortality and ionising radiation exposures among workers employed at the Fernald Feed Materials Production Center (1951-1985).

Authors:  Sharon R Silver; Stephen J Bertke; Misty Jena Hein; Robert D Daniels; Donald A Fleming; Jeri L Anderson; Susan M Pinney; Richard W Hornung; Chih-Yu Tseng
Journal:  Occup Environ Med       Date:  2013-01-15       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.